Newsroom | 5249 results

BOSTON--(BUSINESS WIRE)--Anodyne Nanotech Inc., a clinical-stage biotechnology company simplifying chronic care through transdermal delivery, today announced the closing of a $12.6 million Series A financing. The round was led by Velocity Partners VC and co-led by Evercurious VC, with major participation from Relativity Healthcare Partners. Proceeds from the financing will support the advancement of ANN-101, Anodyne's once-weekly GLP-1 patch for obesity, into a Phase I clinical trial, while acc...

INDIANAPOLIS--(BUSINESS WIRE)--Summit of SNF leaders representing more than 350 facilities identifies clear path forward for operators to take control of transitions of care....

MIAMI & HOUSTON--(BUSINESS WIRE)--The Society for Neuro-Oncology (SNO), the world's largest multidisciplinary organization dedicated to advancing research, education, and clinical care for patients with brain and spinal cord tumors, and OpenEvidence, the leading AI-powered clinical decision support platform, today announced a landmark partnership, designating OpenEvidence as SNO's official generative AI partner. As part of the collaboration, SNO will embed OpenEvidence across its member-facing...

PALO ALTO, Calif.--(BUSINESS WIRE)--Signos announces results from real-world study evaluating weight loss in adults with obesity using the Signos System with Dexcom CGM....

SAN FRANCISCO & INDIANAPOLIS--(BUSINESS WIRE)--ŌURA, maker of the world’s most trusted smart ring, Oura Ring, and LillyDirect, Eli Lilly and Company’s digital health platform designed to connect people living with chronic conditions to the care, support, and prescribed medicines they need, today announced a collaboration enabling savings on the Oura Ring sizing kit. The companies will coordinate to improve access to prescribed treatment and integrated behavioral support tools that complement pre...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced at Aspen Ideas: Health a series of milestones that advance its vision of making glucose biosensing more accessible. Notably, the company announced pediatric clearance for the Stelo Glucose Biosensor and the launch of its fully reimagined Stelo app experience in July for Apple iPhone and Android users in the United States.“Glucose matters for everyone and better understanding it can h...

MILANO--(BUSINESS WIRE)--WISE S.p.A., azienda innovativa di dispositivi medici specializzata in elettrodi impiantabili all'avanguardia per il neuromonitoraggio, la neuromodulazione e le interfacce cervello-computer (BCI, Brain-Computer Interface), oggi ha annunciato la chiusura di un round di finanziamento di serie D sottoscritto in eccesso, per un totale di 30 milioni di euro. Al round ha partecipato anche ENEA Tech and Biomedical, una fondazione italiana dedicata all'innovazione e al trasferi...

MILAN--(BUSINESS WIRE)--WISE S.p.A., société pionnière dans le domaine des dispositifs médicaux et spécialisée dans les électrodes implantables de pointe utilisés pour le neuromonitoring, la neuromodulation et les interfaces cerveau-ordinateur (ICO), a annoncé aujourd'hui la clôture réussie d'un tour de table de série D sursouscrit, d'un montant total de 30 millions d'euros. ENEA Tech and Biomedical, une fondation italienne dédiée à l'innovation et au transfert de technologies dans le secteur b...

MILAAN--(BUSINESS WIRE)--WISE S.p.A., een toonaangevend bedrijf op het gebied van medische hulpmiddelen dat gespecialiseerd is in geavanceerde implanteerbare elektroden voor neuromonitoring, neuromodulatie en hersen-computerinterfaces (BCI), heeft vandaag bekendgemaakt dat de overtekende Serie D-financieringsronde met een totaalbedrag van 30 miljoen euro succesvol is afgerond. Aan deze ronde nam ENEA Tech e Biomedical deel. Dit is een Italiaanse stichting die zich toelegt op innovatie en techno...

MAILAND--(BUSINESS WIRE)--WISE S.p.A., ein wegweisendes Medizintechnikunternehmen, das sich auf fortschrittliche implantierbare Elektroden für Neuromonitoring, Neuromodulation und Gehirn-Computer-Schnittstellen (BCI) spezialisiert hat, gab heute den erfolgreichen Abschluss einer überzeichneten Serie-D-Finanzierungsrunde in Höhe von insgesamt 30 Millionen Euro bekannt. An der Runde beteiligte sich ENEA Tech and Biomedical, eine italienische Stiftung, die sich der Innovation und dem Technologietr...